Insights from long-term ASSURE data for Seladelpar
While the treatment landscape for primary biliary cholangitis (PBC) has long been limited to just a handful of agents with limited efficacy, 2024 saw a major shift in PBC treatment…
News Into the World
While the treatment landscape for primary biliary cholangitis (PBC) has long been limited to just a handful of agents with limited efficacy, 2024 saw a major shift in PBC treatment…
